Abstract
Like other anxiety disorders, panic disorder (PD) with/without agoraphobia is more frequent in women than in men. Identification of the psychosocial contributors to and biological substrates of gender-specific susceptibility for PD may allow a better understanding of the etiology of anxiety disorders in general and would have important implications for prevention, assessment, and treatment of the disorder.
Among psychosocial contributors, childhood sexual abuse and chronic stressors in adult life have been discussed as possible reasons for a higher prevalence of panic disorder in women. Several neurotransmitter systems, including serotonin and glutamate, as well as CO2 sensitivity, which are possibly involved in the etiology of panic disorder have been investigated with regard to their gender specificity. Some data suggest that female reproductive hormones are involved, as periods of fluctuating levels of estrogen and progesterone have been linked to increase or decrease of panic symptomatology. Several genetic studies point to sexual dimorphism, particularly regarding the catechol-O-methyltransferase (COMT) and the monoamine oxidase A (MAOA) genes.
Gender differences have been identified in the pharmacokinetics of psychotropic medication; however, it is unclear whether these differences affect treatment outcome. When treating panic disorder during pregnancy and lactation, a number of safety considerations have to be taken into account.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Andrade L, Eaton WW, Chilcoat HD (1996) Lifetime co-morbidity of panic attacks and major depression in a population-based study: age of onset. Psychol Med 26(5):991–996
Annerbrink K, Westberg L, Olsson M, Andersch S, Sjodin I, Holm G, Allgulander C, Eriksson E (2011) Panic disorder is associated with the Val308Iso polymorphism in the hypocretin receptor gene. Psychiatr Genet 21(2):85–89. doi:10.1097/YPG.0b013e328341a3db
APA (2013) Diagnostic and statistical manual of mental disorders (DSM-5™), 5th edn. American Psychiatric Association, Washington, DC
Asami T, Yamasue H, Hayano F, Nakamura M, Uehara K, Otsuka T, Roppongi T, Nihashi N, Inoue T, Hirayasu Y (2009) Sexually dimorphic gray matter volume reduction in patients with panic disorder. Psychiatry Res 173(2):128–134. doi:10.1016/j.pscychresns.2008.10.004
Bandelow B (1999) Panic and agoraphobia scale (PAS): manual. Hogrefe & Huber Pub, Seattle
Bandelow B, Spath C, Tichauer GA, Broocks A, Hajak G, Ruther E (2002) Early traumatic life events, parental attitudes, family history, and birth risk factors in patients with panic disorder. Compr Psychiatry 43(4):269–278. doi:10.1053/comp.2002.33492
Bandelow B, Sojka F, Broocks A, Hajak G, Bleich S, Rüther E (2006) Panic disorder during pregnancy and postpartum period. Eur Psychiatry 21(7):495–500
Bandelow B, Zohar J, Hollander E, Kasper S, Moller HJ, Allgulander C, Ayuso-Gutierrez J, Baldwin DS, Buenvicius R, Cassano G, Fineberg N, Gabriels L, Hindmarch I, Kaiya H, Klein DF, Lader M, Lecrubier Y, Lepine JP, Liebowitz MR, Lopez-Ibor JJ, Marazziti D, Miguel EC, Oh KS, Preter M, Rupprecht R, Sato M, Starcevic V, Stein DJ, van Ameringen M, Vega J (2008) World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders – first revision. World J Biol Psychiatry 9(4):248–312. doi:10.1080/15622970802465807, 904748294 [pii]
Bandelow B, Saleh K, Pauls J, Domschke K, Wedekind D, Falkai P (2010) Insertion/deletion polymorphism in the gene for angiotensin converting enzyme (ACE) in panic disorder: a gender-specific effect? World J Biol Psychiatry 11(1):66–70. doi:10.3109/15622970701459810
Bandelow B, Domschke K, Baldwin D (2014) Panic disorder and agoraphobia (Oxford Psychiatry Library). Oxford University Press, Oxford
Barzega G, Maina G, Venturello S, Bogetto F (2001) Gender-related differences in the onset of panic disorder. Acta Psychiatr Scand 103(3):189–195
Battaglia M, Pesenti-Gritti P, Spatola CA, Ogliari A, Tambs K (2008) A twin study of the common vulnerability between heightened sensitivity to hypercapnia and panic disorder. Am J Med Genet B Neuropsychiatr Genet 147B(5):586–593. doi:10.1002/ajmg.b.30647
Bayoglu B, Cengiz M, Karacetin G, Uysal O, Kocabasoglu N, Bayar R, Balcioglu I (2012) Genetic polymorphism of angiotensin I-converting enzyme (ACE), but not angiotensin II type I receptor (ATr1), has a gender-specific role in panic disorder. Psychiatry Clin Neurosci 66(2):130–137. doi:10.1111/j.1440-1819.2011.02318.x
Belle D, Doucet J (2003) Poverty, inequality, and discrimination as sources of depression among US women. Psychol Women Q 27(2):101–113. doi:10.1111/1471-6402.00090
Bradwejn J, Koszycki D (2001) Cholecystokinin and panic disorder: past and future clinical research strategies. Scand J Clin Lab Invest Suppl 234:19–27
Braune S, Albus M, Frohler M, Hohn T, Scheibe G (1994) Psychophysiological and biochemical changes in patients with panic attacks in a defined situational arousal. Eur Arch Psychiatry Clin Neurosci 244(2):86–92
Buckwalter JG, Stanczyk FZ, McCleary CA, Bluestein BW, Buckwalter DK, Rankin KP, Chang L, Goodwin TM (1999) Pregnancy, the postpartum, and steroid hormones: effects on cognition and mood. Psychoneuroendocrinology 24(1):69–84
Cannon DM, Klaver JM, Klug SA, Carlson PJ, Luckenbaugh DA, Ichise M, Drevets WC (2013) Gender-specific abnormalities in the serotonin transporter system in panic disorder. Int J Neuropsychopharmacol 16(4):733–743. doi:10.1017/S1461145712000776
Chakravorty SG, Halbreich U (1997) The influence of estrogen on monoamine oxidase activity. Psychopharmacol Bull 33(2):229–233
Clayton AH, Stewart RS, Fayyad R, Clary CM (2006) Sex differences in clinical presentation and response in panic disorder: pooled data from sertraline treatment studies. Arch Womens Ment Health 9(3):151–157. doi:10.1007/s00737-005-0111-y
Cohen LS, Sichel DA, Dimmock JA, Rosenbaum JF (1994a) Impact of pregnancy on panic disorder: a case series. J Clin Psychiatry 55(7):284–288
Cohen LS, Sichel DA, Dimmock JA, Rosenbaum JF (1994b) Postpartum course in women with preexisting panic disorder. J Clin Psychiatry 55(7):289–292
Cohen LS, Sichel DA, Faraone SV, Robertson LM, Dimmock JA, Rosenbaum JF (1996) Course of panic disorder during pregnancy and the puerperium: a preliminary study. Biol Psychiatry 39(11):950–954
Cowley DS, Roy-Byrne PP (1989) Panic disorder during pregnancy. J Psychosom Obstet Gynaecol 10:193–210
Dannon PN, Iancu I, Lowengrub K, Grunhaus L, Kotler M (2006) Recurrence of panic disorder during pregnancy: a 7-year naturalistic follow-up study. Clin Neuropharmacol 29(3):132–137. doi:10.1097/01.WNF.0000220821.73017.14
Deckert J, Nothen MM, Franke P, Delmo C, Fritze J, Knapp M, Maier W, Beckmann H, Propping P (1998) Systematic mutation screening and association study of the A1 and A2a adenosine receptor genes in panic disorder suggest a contribution of the A2a gene to the development of disease. Mol Psychiatry 3(1):81–85
Deckert J, Catalano M, Syagailo YV, Bosi M, Okladnova O, Di Bella D, Nothen MM, Maffei P, Franke P, Fritze J, Maier W, Propping P, Beckmann H, Bellodi L, Lesch KP (1999) Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum Mol Genet 8(4):621–624
Dell’Osso L, Marazziti D, Da Pozzo E, Conversano C, Baroni S, Massimetti G, Martini C, Carmassi C (2012) Gender effect on the relationship between stress hormones and panic-agoraphobic spectrum dimensions in healthy subjects. CNS Spectr 17(4):214–220. doi:10.1017/S1092852912000685
Demetrio FN, Renno J Jr, Gianfaldoni A, Goncalves M, Halbe HW, Filho AH, Gorenstein C (2011) Effect of estrogen replacement therapy on symptoms of depression and anxiety in non-depressive menopausal women: a randomized double-blind, controlled study. Arch Womens Ment Health 14(6):479–486. doi:10.1007/s00737-011-0241-3
Domschke K, Deckert J (2012) Genetics of anxiety disorders – status quo and quo vadis. Curr Pharm Des 18(35):5691–5698
Domschke K, Freitag CM, Kuhlenbaumer G, Schirmacher A, Sand P, Nyhuis P, Jacob C, Fritze J, Franke P, Rietschel M, Garritsen HS, Fimmers R, Nothen MM, Lesch KP, Stogbauer F, Deckert J (2004) Association of the functional V158M catechol-O-methyl-transferase polymorphism with panic disorder in women. Int J Neuropsychopharmacol 7(2):183–188
Domschke K, Deckert J, O’Donovan MC, Glatt SJ (2007) Meta-analysis of COMT val158met in panic disorder: ethnic heterogeneity and gender specificity. Am J Med Genet B Neuropsychiatr Genet 144(5):667–673
Domschke K, Hohoff C, Jacob C, Maier W, Fritze J, Bandelow B, Krakowitzky P, Kastner F, Rothermundt M, Arolt V, Deckert J (2008) Chromosome 4q31-34 panic disorder risk locus: association of neuropeptide Y Y5 receptor variants. Am J Med Genet B Neuropsychiatr Genet 147B(4):510–516. doi:10.1002/ajmg.b.30629
Domschke K, Reif A, Weber H, Richter J, Hohoff C, Ohrmann P, Pedersen A, Bauer J, Suslow T, Kugel H, Heindel W, Baumann C, Klauke B, Jacob C, Maier W, Fritze J, Bandelow B, Krakowitzky P, Rothermundt M, Erhardt A, Binder EB, Holsboer F, Gerlach AL, Kircher T, Lang T, Alpers GW, Strohle A, Fehm L, Gloster AT, Wittchen HU, Arolt V, Pauli P, Hamm A, Deckert J (2011) Neuropeptide S receptor gene – converging evidence for a role in panic disorder. Mol Psychiatry 16(9):938–948. doi:10.1038/mp.2010.81
Domschke K, Tidow N, Kuithan H, Schwarte K, Klauke B, Ambree O, Reif A, Schmidt H, Arolt V, Kersting A, Zwanzger P, Deckert J (2012) Monoamine oxidase A gene DNA hypomethylation – a risk factor for panic disorder? Int J Neuropsychopharmacol 15(9):1217–1228. doi:10.1017/S146114571200020X
Dresler T, Guhn A, Tupak SV, Ehlis AC, Herrmann MJ, Fallgatter AJ, Deckert J, Domschke K (2013) Revise the revised? New dimensions of the neuroanatomical hypothesis of panic disorder. J Neural Transm 120(1):3–29. doi:10.1007/s00702-012-0811-1
Etgen AM, Karkanias GB (1994) Estrogen regulation of noradrenergic signaling in the hypothalamus. Psychoneuroendocrinology 19(5–7):603–610
Facchinetti F, Romano G, Fava M, Genazzani AR (1992) Lactate infusion induces panic attacks in patients with premenstrual syndrome. Psychosom Med 54(3):288–296
Facchinetti F, Tarabusi M, Nappi G (1998) Premenstrual syndrome and anxiety disorders: a psychobiological link. Psychother Psychosom 67(2):57–60
Frackiewicz EJ, Sramek JJ, Cutler NR (2000) Gender differences in depression and antidepressant pharmacokinetics and adverse events. Ann Pharmacother 34(1):80–88
Furuta M, Numakawa T, Chiba S, Ninomiya M, Kajiyama Y, Adachi N, Akema T, Kunugi H (2013) Estrogen, predominantly via estrogen receptor alpha, attenuates postpartum-induced anxiety- and depression-like behaviors in female rats. Endocrinology 154(10):3807–3816. doi:10.1210/en.2012-2136
Gregoire AJ, Kumar R, Everitt B, Henderson AF, Studd JW (1996) Transdermal oestrogen for treatment of severe postnatal depression. Lancet 347(9006):930–933
Griez EJ, Hauzer R, Meijer J (1995) Pregnancy and estrogen-induced panic. Am J Psychiatry 152(11):1688
Guler O, Koken GN, Emul M, Ozbulut O, Gecici O, Uguz F, Gezginc K, Zeytinci IE, Karatayli S, Askin R (2008) Course of panic disorder during the early postpartum period: a prospective analysis. Compr Psychiatry 49(1):30–34. doi:10.1016/j.comppsych.2007.06.007
Halbreich U (1997) Hormonal interventions with psychopharmacological potential: an overview. Psychopharmacol Bull 33(2):281–286
Hamilton SP, Slager SL, Heiman GA, Deng Z, Haghighi F, Klein DF, Hodge SE, Weissman MM, Fyer AJ, Knowles JA (2002) Evidence for a susceptibility locus for panic disorder near the catechol-O-methyltransferase gene on chromosome 22. Biol Psychiatry 51(7):591–601
Hamilton SP, Slager SL, De Leon AB, Heiman GA, Klein DF, Hodge SE, Weissman MM, Fyer AJ, Knowles JA (2004) Evidence for genetic linkage between a polymorphism in the adenosine 2A receptor and panic disorder. Neuropsychopharmacology 29(3):558–565. doi:10.1038/sj.npp.1300311
Harris B, Lovett L, Newcombe RG, Read GF, Walker R, Riad-Fahmy D (1994) Maternity blues and major endocrine changes: Cardiff puerperal mood and hormone study II. BMJ 308(6934):949–953
Harrison PJ, Tunbridge EM (2008) Catechol-O-methyltransferase (COMT): a gene contributing to sex differences in brain function, and to sexual dimorphism in the predisposition to psychiatric disorders. Neuropsychopharmacology 33(13):3037–3045. doi:10.1038/sj.npp.1301543
Hettema JM, Neale MC, Kendler KS (2001) A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry 158(10):1568–1578
Hettema JM, Prescott CA, Myers JM, Neale MC, Kendler KS (2005) The structure of genetic and environmental risk factors for anxiety disorders in men and women. Arch Gen Psychiatry 62(2):182–189. doi:10.1001/archpsyc.62.2.182
Ho HP, Westberg L, Annerbrink K, Olsson M, Melke J, Nilsson S, Baghaei F, Rosmond R, Holm G, Bjorntorp P, Andersch S, Allgulander C, Eriksson E (2004) Association between a functional polymorphism in the progesterone receptor gene and panic disorder in women. Psychoneuroendocrinology 29(9):1138–1141. doi:10.1016/j.psyneuen.2004.01.005
Hosing VG, Schirmacher A, Kuhlenbaumer G, Freitag C, Sand P, Schlesiger C, Jacob C, Fritze J, Franke P, Rietschel M, Garritsen H, Nothen MM, Fimmers R, Stogbauer F, Deckert J (2004) Cholecystokinin- and cholecystokinin-B-receptor gene polymorphisms in panic disorder. J Neural Transm Suppl 68:147–156
Jang KL, Stein MB, Taylor S, Livesley WJ (1999) Gender differences in the etiology of anxiety sensitivity: a twin study. J Gend Specif Med 2(2):39–44
Kelly MM, Forsyth JP, Karekla M (2006) Sex differences in response to a panicogenic challenge procedure: an experimental evaluation of panic vulnerability in a non-clinical sample. Behav Res Ther 44(10):1421–1430. doi:10.1016/j.brat.2005.10.012
Kennedy JL, Bradwejn J, Koszycki D, King N, Crowe R, Vincent J, Fourie O (1999) Investigation of cholecystokinin system genes in panic disorder. Mol Psychiatry 4(3):284–285
Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB (1995) Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry 52(12):1048–1060
Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE (2005) Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62(6):593–602
Kim YR, Min SK, Yu BH (2004) Differences in beta-adrenergic receptor sensitivity between women and men with panic disorder. Eur Neuropsychopharmacol 14(6):515–520. doi:10.1016/j.euroneuro.2004.03.004
Klauke B, Deckert J, Reif A, Pauli P, Domschke K (2010) Life events in panic disorder-an update on “candidate stressors”. Depress Anxiety 27(8):716–730. doi:10.1002/da.20667
Klein DF (1993) False suffocation alarms, spontaneous panics, and related conditions. An integrative hypothesis. Arch Gen Psychiatry 50(4):306–317
Klein DF, Skrobala AM, Garfinkel RS (1994) Preliminary look at the effects of pregnancy on the course of panic disorder. Anxiety 1(5):227–232
Kornstein SG, Schatzberg AF, Thase ME, Yonkers KA, McCullough JP, Keitner GI, Gelenberg AJ, Davis SM, Harrison WM, Keller MB (2000) Gender differences in treatment response to sertraline versus imipramine in chronic depression. Am J Psychiatry 157(9):1445–1452
Kornstein SG, Clayton AH, Soares CN, Padmanabhan SK, Guico-Pabia CJ (2010) Analysis by age and sex of efficacy data from placebo-controlled trials of desvenlafaxine in outpatients with major depressive disorder. J Clin Psychopharmacol 30(3):294–299. doi:10.1097/JCP.0b013e3181dcb594
Le Melledo JM, Baker G (2004) Role of progesterone and other neuroactive steroids in anxiety disorders. Expert Rev Neurother 4(5):851–860. doi:10.1586/14737175.4.5.851
Le Melledo J, Jhangri GS, Lott P, Tait GR, McManus K, Geddes M, Chrapko W, Lara N (2001) Effect of medroxyprogesterone pretreatment on pentagastrin-induced panic symptoms in females with panic disorder. Psychiatry Res 101(3):237–242
Lonsdorf TB, Ruck C, Bergstrom J, Andersson G, Ohman A, Lindefors N, Schalling M (2010) The COMTval158met polymorphism is associated with symptom relief during exposure-based cognitive-behavioral treatment in panic disorder. BMC Psychiatry 10:99. doi:10.1186/1471-244X-10-99
Maier W, Lichtermann D, Minges J, Oehrlein A, Franke P (1993) A controlled family study in panic disorder. J Psychiatr Res 27(Suppl 1):79–87
Maron E, Kuikka JT, Shlik J, Vasar V, Vanninen E, Tiihonen J (2004a) Reduced brain serotonin transporter binding in patients with panic disorder. Psychiatry Res 132(2):173–181. doi:10.1016/j.pscychresns.2003.10.004
Maron E, Tasa G, Toru I, Lang A, Vasar V, Shlik J (2004b) Association between serotonin-related genetic polymorphisms and CCK-4-induced panic attacks with or without 5-hydroxytryptophan pretreatment in healthy volunteers. World J Biol Psychiatry 5(3):149–154
Maron E, Lang A, Tasa G, Liivlaid L, Toru I, Must A, Vasar V, Shlik J (2005) Associations between serotonin-related gene polymorphisms and panic disorder. Int J Neuropsychopharmacol 8(2):261–266. doi:10.1017/S1461145704004985
Maron E, Toru I, Must A, Tasa G, Toover E, Vasar V, Lang A, Shlik J (2007) Association study of tryptophan hydroxylase 2 gene polymorphisms in panic disorder. Neurosci Lett 411(3):180–184. doi:10.1016/j.neulet.2006.09.060
Maron E, Nutt DJ, Kuikka J, Tiihonen J (2010) Dopamine transporter binding in females with panic disorder may vary with clinical status. J Psychiatr Res 44(1):56–59. doi:10.1016/j.jpsychires.2009.04.014
Maron E, Toru I, Hirvonen J, Tuominen L, Lumme V, Vasar V, Shlik J, Nutt DJ, Helin S, Nagren K, Tiihonen J, Hietala J (2011) Gender differences in brain serotonin transporter availability in panic disorder. J Psychopharmacol (Oxford, England) 25(7):952–959. doi:10.1177/0269881110389207
Martin MC, Hoffman PG (1986) The endocrinology of pregnancy. In: Greenspan FS, Forsham PH (eds) Basic and clinical endocrinology, 2nd edn. Lange, Los Altos, pp 476–500
McDonald MM, Navarrete CD, Van Vugt M (2012) Evolution and the psychology of intergroup conflict: the male warrior hypothesis. Philos Trans R Soc Lond B Biol Sci 367(1589):670–679. doi:10.1098/rstb.2011.0301
McManus K, Tait GR, Bellavance F, Le Melledo JM (2001) Effect of ethinyl estradiol on the panic response to the panicogenic agent pentagastrin. J Affect Disord 66(2–3):273–279
McNally RJ (2002) Anxiety sensitivity and panic disorder. Biol Psychiatry 52(10):938–946
Meshberg-Cohen S, Svikis D (2007) Panic disorder, trait anxiety, and alcohol use in pregnant and nonpregnant women. Compr Psychiatry 48(6):504–510. doi:10.1016/j.comppsych.2007.06.004
Minton TD (2013) Jail inmates at midyear 2012 – statistical tables. U.S. Department of Justice, Bureau of Justice Statistics, Washington, DC
Nillni YI, Rohan KJ, Bernstein A, Zvolensky MJ (2010) Premenstrual distress predicts panic-relevant responding to a CO2 challenge among young adult females. J Anxiety Disord 24(4):416–422. doi:10.1016/j.janxdis.2010.02.006
Nillni YI, Toufexis DJ, Rohan KJ (2011) Anxiety sensitivity, the menstrual cycle, and panic disorder: a putative neuroendocrine and psychological interaction. Clin Psychol Rev 31(7):1183–1191. doi:10.1016/j.cpr.2011.07.006
Nocon A, Wittchen HU, Beesdo K, Bruckl T, Hofler M, Pfister H, Zimmermann P, Lieb R (2008) Differential familial liability of panic disorder and agoraphobia. Depress Anxiety 25(5):422–434. doi:10.1002/da.20425
Northcott CJ, Stein MB (1994) Panic disorder in pregnancy. J Clin Psychiatry 55(12):539–542
Ohrmann P, Pedersen A, Braun M, Bauer J, Kugel H, Kersting A, Domschke K, Deckert J, Suslow T (2010) Effect of gender on processing threat-related stimuli in patients with panic disorder: sex does matter. Depress Anxiety 27(11):1034–1043. doi:10.1002/da.20721
Olsson M, Annerbrink K, Westberg L, Melke J, Baghaei F, Rosmond R, Holm G, Andersch S, Allgulander C, Eriksson E (2004) Angiotensin-related genes in patients with panic disorder. Am J Med Genet B Neuropsychiatr Genet 127(1):81–84
Paul SM, Purdy RH (1992) Neuroactive steroids. FASEB J 6(6):2311–2322
Perna G, Brambilla F, Arancio C, Bellodi L (1995) Menstrual cycle-related sensitivity to 35 % CO2 in panic patients. Biol Psychiatry 37(8):528–532. doi:10.1016/0006-3223(94)00154-U
Perna G, Favaron E, Di Bella D, Bussi R, Bellodi L (2005) Antipanic efficacy of paroxetine and polymorphism within the promoter of the serotonin transporter gene. Neuropsychopharmacology 30(12):2230–2235. doi:10.1038/sj.npp.1300822
Pigott TA (1999) Gender differences in the epidemiology and treatment of anxiety disorders. J Clin Psychiatry 60(Suppl 18):4–15
Quast C, Reif A, Bruckl T, Pfister H, Weber H, Mattheisen M, Cichon S, Lang T, Hamm A, Fehm L, Strohle A, Arolt V, Domschke K, Kircher T, Wittchen HU, Pauli P, Gerlach AL, Alpers GW, Deckert J, Rupprecht R, Binder EB, Erhardt A (2014) Gender-specific association of variants in the Akr1c1 gene with dimensional anxiety in patients with panic disorder: additional evidence for the importance of neurosteroids in anxiety? Depress Anxiety. doi:10.1002/da.22229
Raedler TJ, Jahn H, Goedeken B, Gescher DM, Kellner M, Wiedemann K (2006) Megestrol attenuates the hormonal response to CCK-4-induced panic attacks. Depress Anxiety 23(3):139–144. doi:10.1002/da.20147
Reif A, Weber H, Domschke K, Klauke B, Baumann C, Jacob CP, Strohle A, Gerlach AL, Alpers GW, Pauli P, Hamm A, Kircher T, Arolt V, Wittchen HU, Binder EB, Erhardt A, Deckert J (2012) Meta-analysis argues for a female-specific role of MAOA-uVNTR in panic disorder in four European populations. Am J Med Genet B Neuropsychiatr Genet 159B(7):786–793. doi:10.1002/ajmg.b.32085
Reif A, Richter J, Straube B, Hofler M, Lueken U, Gloster AT, Weber H, Domschke K, Fehm L, Strohle A, Jansen A, Gerlach A, Pyka M, Reinhardt I, Konrad C, Wittmann A, Pfleiderer B, Alpers GW, Pauli P, Lang T, Arolt V, Wittchen HU, Hamm A, Kircher T, Deckert J (2013) MAOA and mechanisms of panic disorder revisited: from bench to molecular psychotherapy. Mol Psychiatry. doi:10.1038/mp.2012.172
Rothe C, Koszycki D, Bradwejn J, King N, Deluca V, Tharmalingam S, Macciardi F, Deckert J, Kennedy JL (2006) Association of the Val158Met catechol O-methyltransferase genetic polymorphism with panic disorder. Neuropsychopharmacology 31(10):2237–2242
Ryan J, Scali J, Carriere I, Scarabin PY, Ritchie K, Ancelin ML (2011) Estrogen receptor gene variants are associated with anxiety disorders in older women. Psychoneuroendocrinology 36(10):1582–1586. doi:10.1016/j.psyneuen.2011.04.011
Sacher J, Wilson AA, Houle S, Rusjan P, Hassan S, Bloomfield PM, Stewart DE, Meyer JH (2010) Elevated brain monoamine oxidase A binding in the early postpartum period. Arch Gen Psychiatry 67(5):468–474. doi:10.1001/archgenpsychiatry.2010.32
Saeki Y, Watanabe T, Ueda M, Saito A, Akiyama K, Inoue Y, Hirokane G, Morita S, Yamada N, Shimoda K (2009) Genetic and pharmacokinetic factors affecting the initial pharmacotherapeutic effect of paroxetine in Japanese patients with panic disorder. Eur J Clin Pharmacol 65(7):685–691. doi:10.1007/s00228-009-0633-8
Sakai Y, Nishikawa M, Leyton M, Benkelfat C, Young SN, Diksic M (2006) Cortical trapping of alpha-[(11)C]methyl-l-tryptophan, an index of serotonin synthesis, is lower in females than males. Neuroimage 33(3):815–824. doi:10.1016/j.neuroimage.2006.08.004
Samochowiec J, Hajduk A, Samochowiec A, Horodnicki J, Stepien G, Grzywacz A, Kucharska-Mazur J (2004) Association studies of MAO-A, COMT, and 5-HTT genes polymorphisms in patients with anxiety disorders of the phobic spectrum. Psychiatry Res 128(1):21–26. doi:10.1016/j.psychres.2004.05.012
Schmidt NB, Koselka M (2000) Gender differences in patients with panic disorder: evaluating cognitive mediation of phobic avoidance. Cogn Ther Res 24(5):533–550. doi:10.1023/A:1005562011960
Schmidt ME, Matochik JA, Goldstein DS, Schouten JL, Zametkin AJ, Potter WZ (1997) Gender differences in brain metabolic and plasma catecholamine responses to alpha 2-adrenoceptor blockade. Neuropsychopharmacology 16(4):298–310
Seeman MV (1997) Psychopathology in women and men: focus on female hormones. Am J Psychiatry 154(12):1641–1647
Shear MK, Brown TA, Barlow DH, Money R, Sholomskas DE, Woods SW, Gorman JM, Papp LA (1997) Multicenter collaborative panic disorder severity scale. Am J Psychiatry 154(11):1571–1575
Sholomskas DE, Wickamaratne PJ, Dogolo L, O’Brien DW, Leaf PJ, Woods SW (1993) Postpartum onset of panic disorder: a coincidental event? J Clin Psychiatry 54(12):476–480
Sichel DA, Cohen LS, Robertson LM, Ruttenberg A, Rosenbaum JF (1995) Prophylactic estrogen in recurrent postpartum affective disorder. Biol Psychiatry 38(12):814–818
Smoller JW, Pollack MH, Wassertheil-Smoller S, Jackson RD, Oberman A, Wong ND, Sheps D (2007) Panic attacks and risk of incident cardiovascular events among postmenopausal women in the Women’s Health Initiative Observational Study. Arch Gen Psychiatry 64(10):1153–1160. doi:10.1001/archpsyc.64.10.1153
Sramek JJ, Cutler NR (2011) The impact of gender on antidepressants. Curr Top Behav Neurosci 8:231–249. doi:10.1007/7854_2010_118
Stein P, Savli M, Wadsak W, Mitterhauser M, Fink M, Spindelegger C, Mien LK, Moser U, Dudczak R, Kletter K, Kasper S, Lanzenberger R (2008) The serotonin-1A receptor distribution in healthy men and women measured by PET and [carbonyl-11C]WAY-100635. Eur J Nucl Med Mol Imaging 35(12):2159–2168. doi:10.1007/s00259-008-0850-x
Steiner M, Ravindran AV, LeMelledo JM, Carter D, Huang JO, Anonychuk AM, Simpson SD (2008) Luteal phase administration of paroxetine for the treatment of premenstrual dysphoric disorder: a randomized, double-blind, placebo-controlled trial in Canadian women. J Clin Psychiatry 69(6):991–998
Stewart SH, Taylor S, Baker JM (1997) Gender differences in dimensions of anxiety sensitivity. J Anxiety Disord 11(2):179–200
Tunbridge EM, Harrison PJ, Warden DR, Johnston C, Refsum H, Smith AD (2008) Polymorphisms in the catechol-O-methyltransferase (COMT) gene influence plasma total homocysteine levels. Am J Med Genet B Neuropsychiatr Genet 147B(6):996–999. doi:10.1002/ajmg.b.30700
Unschuld PG, Ising M, Erhardt A, Lucae S, Kohli M, Kloiber S, Salyakina D, Thoeringer CK, Kern N, Lieb R, Uhr M, Binder EB, Muller-Myhsok B, Holsboer F, Keck ME (2008) Polymorphisms in the galanin gene are associated with symptom-severity in female patients suffering from panic disorder. J Affect Disord 105(1–3):177–184
Unschuld PG, Ising M, Roeske D, Erhardt A, Specht M, Kloiber S, Uhr M, Muller-Myhsok B, Holsboer F, Binder EB (2010) Gender-specific association of galanin polymorphisms with HPA-axis dysregulation, symptom severity, and antidepressant treatment response. Neuropsychopharmacology 35(7):1583–1592. doi:10.1038/npp.2010.30
van Beek N, Griez E (2003) Anxiety sensitivity in first-degree relatives of patients with panic disorder. Behav Res Ther 41(8):949–957
van Duinen MA, Schruers KR, Jaegers E, Maes M, Griez EJ (2004) Salivary cortisol in panic: are males more vulnerable? Neuro Endocrinol Lett 25(5):386–390
Verburg C, Griez E, Meijer J (1994) Increase of panic during the second half of pregnancy. Eur Psychiatry 9:260–261
Vickers K, McNally RJ (2004) Is premenstrual dysphoria a variant of panic disorder? A review. Clin Psychol Rev 24(8):933–956. doi:10.1016/j.cpr.2004.08.001
Vieland VJ, Goodman DW, Chapman T, Fyer AJ (1996) New segregation analysis of panic disorder. Am J Med Genet 67(2):147–153
Villeponteaux VA, Lydiard RB, Laraia MT, Stuart GW, Ballenger JC (1992) The effects of pregnancy on preexisting panic disorder. J Clin Psychiatry 53(6):201–203
Weber H, Scholz CJ, Domschke K, Baumann C, Klauke B, Jacob CP, Maier W, Fritze J, Bandelow B, Zwanzger PM, Lang T, Fehm L, Strohle A, Hamm A, Gerlach AL, Alpers GW, Kircher T, Wittchen HU, Arolt V, Pauli P, Deckert J, Reif A (2012) Gender differences in associations of glutamate decarboxylase 1 gene (GAD1) variants with panic disorder. PLoS One 7(5):e37651. doi:10.1371/journal.pone.0037651
Wedekind D, Sprute A, Broocks A, Huther G, Engel K, Falkai P, Bandelow B (2008) Nocturnal urinary cortisol excretion over a randomized controlled trial with paroxetine vs. placebo combined with relaxation training or aerobic exercise in panic disorder. Curr Pharm Des 14(33):3518–3524
Weissman MM, Bland RC, Canino GJ, Faravelli C, Greenwald S, Hwu HG, Joyce PR, Karam EG, Lee CK, Lellouch J, Lepine JP, Newman SC, Oakley-Browne MA, Rubio-Stipec M, Wells JE, Wickramaratne PJ, Wittchen HU, Yeh EK (1997) The cross-national epidemiology of panic disorder. Arch Gen Psychiatry 54(4):305–309
Wisner KL, Peindl KS, Hanusa BH (1996) Effects of childbearing on the natural history of panic disorder with comorbid mood disorder. J Affect Disord 41(3):173–180
Wittchen HU, Jacobi F, Rehm J, Gustavsson A, Svensson M, Jonsson B, Olesen J, Allgulander C, Alonso J, Faravelli C, Fratiglioni L, Jennum P, Lieb R, Maercker A, van Os J, Preisig M, Salvador-Carulla L, Simon R, Steinhausen HC (2011) The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 21(9):655–679. doi:10.1016/j.euroneuro.2011.07.018
Yevtushenko OO, Oros MM, Reynolds GP (2010) Early response to selective serotonin reuptake inhibitors in panic disorder is associated with a functional 5-HT1A receptor gene polymorphism. J Affect Disord 123(1–3):308–311. doi:10.1016/j.jad.2009.09.007
Yonkers KA, Zlotnick C, Allsworth J, Warshaw M, Shea T, Keller MB (1998) Is the course of panic disorder the same in women and men? Am J Psychiatry 155(5):596–602
Young EA, Altemus M, Parkison V, Shastry S (2001) Effects of estrogen antagonists and agonists on the ACTH response to restraint stress in female rats. Neuropsychopharmacology 25(6):881–891
Young EA, Kornstein SG, Marcus SM, Harvey AT, Warden D, Wisniewski SR, Balasubramani GK, Fava M, Trivedi MH, John Rush A (2009) Sex differences in response to citalopram: a STAR*D report. J Psychiatr Res 43(5):503–511. doi:10.1016/j.jpsychires.2008.07.002
Zwanzger P, Domschke K, Bradwejn J (2012) Neuronal network of panic disorder: the role of the neuropeptide cholecystokinin. Depress Anxiety 29(9):762–774. doi:10.1002/da.21919
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Bandelow, B., Domschke, K. (2015). Panic Disorder. In: Stein, D., Vythilingum, B. (eds) Anxiety Disorders and Gender. Springer, Cham. https://doi.org/10.1007/978-3-319-13060-6_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-13060-6_2
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-13059-0
Online ISBN: 978-3-319-13060-6
eBook Packages: MedicineMedicine (R0)